[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2113910T3 - Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus. - Google Patents

Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.

Info

Publication number
ES2113910T3
ES2113910T3 ES92118227T ES92118227T ES2113910T3 ES 2113910 T3 ES2113910 T3 ES 2113910T3 ES 92118227 T ES92118227 T ES 92118227T ES 92118227 T ES92118227 T ES 92118227T ES 2113910 T3 ES2113910 T3 ES 2113910T3
Authority
ES
Spain
Prior art keywords
concentrate
trombine
procedure
preparation
against viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92118227T
Other languages
English (en)
Inventor
Hermann E Karges
Horst Naumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centeon Pharma GmbH
Original Assignee
Centeon Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centeon Pharma GmbH filed Critical Centeon Pharma GmbH
Application granted granted Critical
Publication of ES2113910T3 publication Critical patent/ES2113910T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO QUE PERMITE OBTENER DE FORMA SENCILLA, A PARTIR DE UN CONCENTRADO PASTEURIZADO DEL COMPLEJO DE PROTROMBINA, UN CONCENTRADO DE TROMBINA A PRUEBA DE VIRUS, Y SU UTILIZACION COMO MEDICAMENTO.
ES92118227T 1991-11-19 1992-10-24 Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus. Expired - Lifetime ES2113910T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4137996A DE4137996A1 (de) 1991-11-19 1991-11-19 Verfahren zur herstellung eines virussicheren thrombinkonzentrates

Publications (1)

Publication Number Publication Date
ES2113910T3 true ES2113910T3 (es) 1998-05-16

Family

ID=6445112

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92118227T Expired - Lifetime ES2113910T3 (es) 1991-11-19 1992-10-24 Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.

Country Status (12)

Country Link
US (1) US5723123A (es)
EP (1) EP0543178B1 (es)
JP (1) JPH05194261A (es)
KR (1) KR100261360B1 (es)
AT (1) ATE162218T1 (es)
AU (1) AU658238B2 (es)
CA (1) CA2083243C (es)
DE (2) DE4137996A1 (es)
DK (1) DK0543178T3 (es)
ES (1) ES2113910T3 (es)
GR (1) GR3026253T3 (es)
NO (1) NO307473B1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
JPH07308190A (ja) * 1994-05-18 1995-11-28 Green Cross Corp:The トロンビンの製造方法
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
AUPN436995A0 (en) * 1995-07-24 1995-08-17 Csl Limited Method for the production of thrombin
JP3944267B2 (ja) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US6096309A (en) 1997-06-18 2000-08-01 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
AU784808B2 (en) * 2001-04-02 2006-06-29 Kedrion Melville Inc. Prion and viral clearance process
US7201901B2 (en) * 2002-05-23 2007-04-10 Ortho-Clinical Diagnostics, Inc. Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2394566A (en) * 1942-07-13 1946-02-12 Parke Davis & Co Process for obtaining products derived from blood
US4357321A (en) * 1980-01-28 1982-11-02 Baxter Travenol Laboratories, Inc. Method and composition for treating clotting factor inhibitors
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
US4380511A (en) * 1981-08-12 1983-04-19 Miles Laboratories, Inc. Purification of bovine thrombin
US4965203A (en) * 1987-01-28 1990-10-23 Warner-Lambert Company Purified thrombin preparations
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5525498A (en) * 1989-12-18 1996-06-11 Warner-Lambert Company Process for preparing an ultra-pure thrombin preparation
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
ES2131504T3 (es) * 1990-02-20 1999-08-01 Baxter Int Trombina humana purificada viricamente segura.
JPH0813750B2 (ja) * 1990-03-01 1996-02-14 持田製薬株式会社 経口用トロンビン製剤
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
ATE143411T1 (de) * 1991-03-28 1996-10-15 Warner Lambert Co Hochreine thrombinzubereitung
JPH04365481A (ja) * 1991-06-11 1992-12-17 Green Cross Corp:The トロンビンの製造法
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT397390B (de) * 1992-04-06 1994-03-25 Immuno Ag Verfahren zur spaltung von proteinen
US5428014A (en) * 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography

Also Published As

Publication number Publication date
DE59209133D1 (de) 1998-02-19
EP0543178A3 (en) 1994-07-06
DK0543178T3 (da) 1998-09-14
AU658238B2 (en) 1995-04-06
NO307473B1 (no) 2000-04-10
EP0543178B1 (de) 1998-01-14
CA2083243A1 (en) 1993-05-20
ATE162218T1 (de) 1998-01-15
KR930009612A (ko) 1993-06-21
JPH05194261A (ja) 1993-08-03
EP0543178A2 (de) 1993-05-26
CA2083243C (en) 2005-02-22
GR3026253T3 (en) 1998-05-29
US5723123A (en) 1998-03-03
NO924453L (no) 1993-05-20
DE4137996A1 (de) 1993-05-27
KR100261360B1 (ko) 2000-07-01
NO924453D0 (no) 1992-11-18
AU2850292A (en) 1993-05-20

Similar Documents

Publication Publication Date Title
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
PL296460A1 (en) Method of obtaining a trombine preparation effectively protected against viruses
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
ES2087156T3 (es) Metodos para la inactivacion de virus en composiciones farmaceuticas contaminadas por virus.
HK45193A (en) Ozone decontamination of blood and blood products
ES2157109T3 (es) Virus citopaticos para el tratamiento y la profilasis de la neoplasia.
MX9101540A (es) Polimeros de proantocianidina que tienen actividad antiviral y metodos para obtener los mismos
DK1195159T3 (da) Terapeutisk kombination af ascorbat med lysin og arginin til forebyggelse eller behandling af cancer
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
IL88731A0 (en) Non-reverting rna viruses
DK178188D0 (da) Antivirusmiddel
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
ATE88752T1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
ATE132527T1 (de) Nicht-zurückmutierende rna-viren
DE69006187D1 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
SU1565027A1 (ru) Инактиватор вируса западного нила
MX9400210A (es) Tratamiento de infecciones virales.
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 543178

Country of ref document: ES